InnoCare Pharma Limited (SHA:688428)
China flag China · Delayed Price · Currency is CNY
30.75
+0.59 (1.96%)
At close: Aug 5, 2025, 2:57 PM CST

InnoCare Pharma Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2020
34,57011,87212,41521,82818,69314,633
Upgrade
Market Cap Growth
98.27%-4.38%-43.12%16.78%27.74%-
Upgrade
Enterprise Value
29,2266,1344,75013,72613,83911,649
Upgrade
Last Close Price
30.7512.2811.5014.11--
Upgrade
PS Ratio
28.2211.7616.8134.9017.9210727.94
Upgrade
PB Ratio
5.111.761.732.863.304.63
Upgrade
P/TBV Ratio
5.331.841.812.893.364.78
Upgrade
P/OCF Ratio
----111.89-
Upgrade
EV/Sales Ratio
24.326.086.4321.9513.278540.54
Upgrade
Debt / Equity Ratio
0.230.230.230.200.230.37
Upgrade
Asset Turnover
0.130.100.070.070.180
Upgrade
Inventory Turnover
1.401.291.393.8111.13-
Upgrade
Quick Ratio
7.327.014.134.4319.2938.75
Upgrade
Current Ratio
7.847.454.214.4819.4939.18
Upgrade
Return on Equity (ROE)
-4.24%-6.50%-8.71%-13.44%-1.51%-368.36%
Upgrade
Return on Assets (ROA)
-2.63%-3.52%-4.15%-5.48%-1.91%-9.77%
Upgrade
Return on Capital (ROIC)
-3.19%-3.97%-4.66%-6.02%-2.02%-10.37%
Upgrade
Earnings Yield
-0.81%-3.71%-5.08%-4.06%-0.34%-2.67%
Upgrade
FCF Yield
-0.85%-3.74%-7.41%-3.63%-0.01%-2.89%
Upgrade
Buyback Yield / Dilution
7.72%0.67%-15.31%-8.29%-41.21%-321.19%
Upgrade
Updated Nov 11, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.